Intuitive Surgical assumed with a Neutral at UBS

UBS analyst Danielle Antalffy assumed coverage of Intuitive Surgical with a Neutral rating and $278 price target as part of a sector note on U.S. Medical Supplies and Devices. While Intuitive is one of the few true growth stocks in large-cap MedTech, the firm doesn’t have a clear view into estimate upside with what it sees as prolonged or delayed purchasing cycles in this tough macroeconomic environment, the analyst tells investors in a research note.